Revolutionary technology allows brain surgery without breaking the skin

Zelma KissUniversity of Calgary research study benefits people with severe essential tremor

Elias Pharaon is 85 years old and can sign his name for the first time in five years thanks to a new way to do brain surgery. Performed by a team of University of Calgary physicians and researchers with the Hotchkiss Brain Institute, magnetic resonance guided focused ultrasound (MRgFUS) is a new technology that allows surgeons to access the brain without cutting the skin or drilling into the skull. Continue reading

UCalgary researcher leads Canada-wide clinical trial using anti-psychotic drug to treat ALS

Lawrence Korngut

Pimozide, known for treating certain psychiatric conditions, may stabilize progression of the disease. The University of Calgary’s Lawrence Korngut is leading a clinical trial with nine hospital centres across Canada to recruit patients for further study.
If you took part in the ALS Ice Bucket Challenge, you may have wondered where the money raised by the millions of people who poured buckets of ice water over their heads went. Some of those funds are being invested in a University of Calgary research study investigating a potential drug treatment for amyotrophic lateral sclerosis (ALS) patients. Continue reading

Is your stress changing my brain?

Bains & Sterley
Bains & Sterley

UCalgary researchers discover stress isn’t just contagious; it alters the brain on a cellular level

In a new study in Nature Neuroscience, Jaideep Bains, PhD, and his team at the Cumming School of Medicine’s Hotchkiss Brain Institute (HBI), at the University of Calgary have discovered that stress transmitted from others can change the brain in the same way as a real stress does. The study, in mice, also shows that the effects of stress on the brain are reversed in female mice following a social interaction. This was not true for male mice.
Continue reading

Researchers suggest a new approach to improve neuron grafts in people suffering from Parkinson’s disease

Martin LévesqueTreating people affected by Parkinson’s disease by grafting healthy neurons is an attractive idea which has not yet given the anticipated results up until now.  Even if grafted neurons survive, they are not able to recreate the dopaminergic neuron circuits that are essential for normal brain function.  An international team led by Martin Lévesque, professor at Université Laval and researcher at the CERVO Brain Research Centre, might have figured out why.  In a recent edition of Nature Communications, the researchers propose a “recipe” to produce neurons that could reconstitute the neuron circuits that are destroyed by Parkinson’s disease. Continue reading

Progression of Parkinson’s disease follows brain connectivity

Alain Dagher
Dr. Alain Dagher

A study by a group of researchers led by Alain Dagher from The Montreal Neurological Institute and Hospital of McGill University has tested the theory that brain degeneration in Parkinson’s disease (PD) originates in subcortical regions and spreads along neural networks to the cerebral cortex. By analyzing data on PD patients and healthy controls collected over one year, the researchers found that brain regions closely connected to subcortical regions showed the most degeneration over the one-year period in PD patients, and that this happens earlier than previously thought. Continue reading

Researcher Hideto Takahashi decrypts signals from neurons

Hideto Takahashi
Hideto Takahashi

A discovery by Hideto Takahashi and his team paves the way for a better understanding of the mechanisms of neuropsychiatric disorders.

Did you know? Your body is made up of a hundred billion nerve cells that, like small computers, receive, process and deliver crucial information to your body. These machines are your neurons. They form the very foundation of your nervous system. It is through them that your brain converts the data transmitted by your retina into images and that your mood adapts to the situations you are living. Continue reading

A non-invasive method to detect Alzheimer’s disease

John Breitner
John Breitner

Volume in brain region linked to physiological changes characteristic of AD

New research has drawn a link between changes in the brain’s anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer’s disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear. Continue reading

How chronic social stress can lead to depression

Caroline Ménard
Caroline Ménard

A recent publication by Caroline Ménard shows that chronic stress, as occurs in cases of bullying, can make the blood-brain barrier more permeable to contaminants and microbes that may be in the blood.  As the brains of depressed individuals show signs of inflammation, Caroline Ménard and her colleagues had hypothesized that leakiness of the blood brain barrier could allow molecules and microbes to reach the brain, causing inflammation. Continue reading

SickKids researchers discover precise molecular mechanisms that can influence memory

Zhengping Jia
Zhengping Jia

Learning and memory are crucial parts of human cognition, yet the biological processes that govern how we learn and store different types of memories are poorly understood. Although a cellular process called synaptic plasticity has long been thought to contribute to learning and memory, many of the neural mechanisms behind synaptic plasticity have remained unclear.

In a recently published study entitled The C-terminal tails of endogenous GluA1 and GluA2 differentially contribute to hippocampal synaptic plasticity and learning, researchers from The Hospital for Sick Children (SickKids) have discovered the precise neuronal mechanisms that can regulate synaptic plasticity to influence distinct forms of memory. We sat down with Dr. Zhengping Jia, a Senior Scientist in the Neurosciences & Mental Health Program at SickKids who led the study, published online in Nature Neuroscience. Continue reading

Canadian Researchers Reveal How Certain Chronic Diseases Can Worsen The Effects of Multiple Sclerosis

Ruth Ann Marrie
Ruth Ann Marrie

Multiple Sclerosis is known as a progressive disease in which symptoms worsen over time. But for some 85% of those who suffer, the first stages of the illness come in waves. The individual may feel perfectly well some days while others are marked with worsening or new symptoms.

Officially this condition is known as relapsing remitting multiple sclerosis (MS) and it is the focus of a large Canadian conglomerate known as the CIHR Team in Epidemiology and Impact of Comorbidity on Multiple Sclerosis, or ECoMS. As the name implies, the group aims to determine how co-existing chronic diseases – comorbidities – affect those suffering with MS. Last week, representatives of the team, headed by Dr. Ruth Ann Marrie at the University of Manitoba and Director of Manitoba’s MS Clinic at Health Sciences Centre Winnipeg, revealed their findings in the journal, Neurology. Continue reading